Insmed | INSM - Dochód Netto





Dochód Netto Zmiana Data
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
DBV Technologies USD -47.6M 2.77M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Novartis USD 3.16B 747M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03